tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
NBIX is currently covered by 21 analysts with an average price target of $191.23. This is a potential upside of $37.47 (25.34%) from yesterday's end of day stock price of $152.57.
Neurocrine Biosciences's activity chart (see below) currently has 671 price targets and 504 ratings on display. The stock rating distribution of NBIX is 86.76% BUY and 13.24% HOLD.
Analysts average stock forecasts to be materialized ratio is 82.88% with an average time for these price targets to be met of 318.11 days.
Highest price target for NBIX is $249, Lowest price target is $140, average price target is $191.23.
Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 13-Aug-2026. First documented stock forecast 16-Dec-2014.
Currently out of the existing stock ratings of NBIX, 59 are a BUY (86.76%), 9 are a HOLD (13.24%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-Apr-2026
$182
$29.43 (19.29%)
$196
Buy Since 02-Feb-2021
$213
$60.43 (39.61%)
$200
Buy Since 09-Jun-2020
$194
$41.43 (27.15%)
$176
Buy Since 14-Oct-2024
$210
$57.43 (37.64%)
$207
Buy Since 21-Oct-2025
$249
$96.43 (63.20%)
$246
What is NBIX (Neurocrine Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on NBIX (Neurocrine Biosciences) with a proven track record?
Which analyst has the most public recommendations on NBIX (Neurocrine Biosciences)?
Which analyst is the currently most bullish on NBIX (Neurocrine Biosciences)?
Which analyst is the currently most reserved on NBIX (Neurocrine Biosciences)?
